Search

Author/Creator Herrera, Alex F

1. Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial. Issue 1 (January 2023)

Authors:
Herrera, Alex F; Chen, Lu; Nieto, Yago; Holmberg, Leona; Johnston, Patrick; Mei, Matthew; Popplewell, Leslie; Armenian, Saro; Cao, Thai; Farol, Leonardo; Sahebi, Firoozeh; Spielberger, Ricardo; Chen, Robert; Nademanee, Auayporn; Puverel, Sandrine; Nwangwu, Mary; Lee, Peter; Song, Joo; Skarbnik, A...
Journal:
Lancet
Issue:
Volume 10:Issue 1(2023)
Page Start:
e14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial. Issue 1 (January 2019)

Authors:
Locke, Frederick L; Ghobadi, Armin; Jacobson, Caron A; Miklos, David B; Lekakis, Lazaros J; Oluwole, Olalekan O; Lin, Yi; Braunschweig, Ira; Hill, Brian T; Timmerman, John M; Deol, Abhinav; Reagan, Patrick M; Stiff, Patrick; Flinn, Ian W; Farooq, Umar; Goy, Andre; McSweeney, Peter A; Munoz, Javie...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 1(2019)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search